Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06436846 · ClinicalTrials.gov registry record
Genomic Risk in Retroperitoneal Sarcoma
A clinical trial of Soft Tissue Sarcoma and Retroperitoneal Liposarcoma, sponsored by Fox Chase Cancer Center.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06436846 is a study of Soft Tissue Sarcoma and Retroperitoneal Liposarcoma that is actively recruiting participants, run by Fox Chase Cancer Center. The registered enrollment target is 50 participants, below the 78-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (36% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06436846, a study of Soft Tissue Sarcoma and Retroperitoneal Liposarcoma, is actively recruiting participants, sponsored by Fox Chase Cancer Center.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The protocol intends to explore the biology which may underlie recurrences of retroperitoneal liposarcoma. Surgery remains the only curative intent intervention for this disease. Often, tumors recur in locations within the retroperitoneum remote from the original primary tumor. This study hypothesizes that normal appearing retroperitoneal fat actually harbors underlying genetic changes which predispose to development of future liposarcoma. To accomplish this goal, retroperitoneal fat is sampled from quadrants within and remote from the primary tumor and is subsequently subjected to genetic analyses looking for such predisposing factors.
Conditions Studied
Interventions
- OTHER Biospecimen sample collection during standard-of-care surgery
Study Locations (1)
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-03-07 |
| Est. Completion | 2027-08-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06436846
The ClinicalTrials.gov registry entry for NCT06436846 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 78-participant average among 55 other Soft Tissue Sarcoma trials with a reported enrollment target (36% lower). The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Soft Tissue Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen sample collection during standard-of-care surgery is the first listed.
NCT06436846 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06436846 about?
NCT06436846 is a clinical study titled "Genomic Risk in Retroperitoneal Sarcoma". The protocol intends to explore the biology which may underlie recurrences of retroperitoneal liposarcoma. Surgery remains the only curative intent intervention for this disease. Often, tumors recur in locations within the retroperitoneum remote from the original primary tumor. This study hypothesiz...
What is the current status of trial NCT06436846?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-03-07. Estimated completion is 2027-08-01.
What conditions does trial NCT06436846 study?
This clinical trial studies the following conditions: Soft Tissue Sarcoma, Retroperitoneal Liposarcoma.
What interventions are being tested in trial NCT06436846?
The interventions under investigation include: Biospecimen sample collection during standard-of-care surgery (OTHER).
Who is sponsoring clinical trial NCT06436846?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06436846 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Soft Tissue Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Exercise and Soft Tissue Sarcoma
RECRUITING · NA
-
Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants
RECRUITING · Phase 1
-
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma
RECRUITING · Phase 2
-
Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma
RECRUITING · NA
-
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.